Memantine in Patients With Chronic Glaucoma

Phase 3

Completed

• Conditions: Open-Angle Glaucoma

• Registration Number: NCT00141882
• Lead Sponsor: Allergan

Brief Summary

Randomized double-masked clinical trial of memantine in patients with glaucoma

Detailed Description

Not available

Study Timeline

• Study Start: 1999-03
• Study First Submitted: 2005-08-31
• Study First Submitted QC: 2005-08-31
• Study First Posted: 2005-09-02
• Primary Completion: 2006-01
• Study Completion: 2006-08
• Status Verified: 2010-11
• Last Update Submitted: 2010-11-03
• Last Update Posted: 2010-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1119

Inclusion Criteria

• Glaucoma damage on examination of visual field and optic disc
• Good visual acuity (with glasses if needed)

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Progression of glaucoma